Nalidixic Acid

In some countries, this medicine may only be approved for veterinary use.

In the US, Nalidixic Acid (nalidixic acid systemic) is a member of the following drug classes: quinolones, urinary anti-infectives and is used to treat Bladder Infection and Prevention of Bladder infection.

US matches:

• Nalidixic Acid


• Nalidixic Acid Suspension

UK matches:

• Nalidixic Acid 300mg/5ml Oral Suspension
• Nalidixic Acid 300mg/5ml Oral Suspension (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MB02

CAS registry number (Chemical Abstracts Service)

0000389-08-2

Chemical Formula

C12-H12-N2-O3

Molecular Weight

232

Therapeutic Category

Antiinfective, quinolin-derivative

Chemical Name

1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-

Foreign Names

• Acidum Nalidixicum (Latin)
• Nalidixinsäure (German)
• Acide nalidixique (French)
• Acido nalidixico (Spanish)

Generic Names

• Acide nalidixique (OS: DCF)
• Acido nalidixico (OS: DCIT)
• Nalidixic Acid (OS: BAN, USAN)
• Win 18320 (IS)
• Acidum nalidixicum (PH: Ph. Eur. 6)
• Nalidixic Acid (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
• Nalidixinsäure (PH: Ph. Eur. 6)
• Nalidixique (acide) (PH: Ph. Eur. 6)

Brand Names

• Acido Nalidixico L.CH.
  Chile, Chile



• Acido Nalidixico
  Prodes, Oman



• Degram
  Doctor's Chemical Work, Bangladesh



• Diarlop
  Jagson Pal, India



• Dixicon
  Jayson, Bangladesh



• Gramazine
  Johnson, Taiwan



• Gramoneg
  Ranbaxy, India



• Nal-acid
  Farmanic Chemipharma, Greece



• Naldix
  Shiba, Yemen



• Nalid
  Square, Bangladesh



• Nalidix
  Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Tunisia; Dar-Al-Dawa, Yemen



• Nalidixic Acid Malpharm
  International Medical, Hong Kong; Malaysia Chemist, Singapore



• Nalidixic Acid
  Remedica, Cyprus; Watson, United States



• Naligram
  Acme, Bangladesh; Acme, Sri Lanka



• Nalix
  Aristopharma, Bangladesh



• Nalixid
  Zentiva, Romania



• Nebactil
  Beximco, Bangladesh



• Negadix
  CFL, India



• NegGram
  Sanofi-Aventis, United States



• Negram
  Sanofi-Aventis, Bahrain; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Ireland; Sanofi-Synthelabo, Jordan



• Negram (veterinary use)
  Sanofi-Synthelabo, United Kingdom



• Nelidix
  Actavis, Georgia



• Nevigramon
  Chinoin, Poland; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hungary



• Puromylon
  Aspen Pharmacare, South Africa



• Ultragam
  Globe, Bangladesh



• Unaserus
  Isei, Japan



• Uriben
  Rosemont, United Kingdom



• Uriben (veterinary use)
  Rosemont, United Kingdom



• Urineg
  Armoxindo, Indonesia



• Urotan
  Markos, Peru



• Utirex
  Opsonin, Bangladesh



• Winlomylon
  Adcock Ingram Pharmaceuticals, South Africa



• Wintomilon
  Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal



• Wintomylon
  Nipro PatchNipuropatchi, Japan; Sanofi-Aventis, Brazil; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Hong Kong; Sanofi-Synthelabo, Peru



• Wintomylon (pediatric)
  Daiichi Sankyo, Japan



• Wintorin
  Sankei Yakuhin, Japan



• Youdix
  Yoshindo, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.